Marc van Dijk

Marc van Dijk

Company: MiNK Therapeutics

Job title: Chief Scientific Officer


Assessing Techniques to Improve the TME For Therapeutic Discovery & Development 9:00 am

Highlighting the importance of designing tumour models that accurately represent the immune component to effectively evaluate immuno-oncology therapies  Uncovering methods for TME remodelling to promote immune activation  Implementing tumour models including CDX/PDX mice and 3D tissue model systems to assess combination therapies of cancer vaccines with checkpoint inhibitorsRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.